Upgrade to SI Premium - Free Trial

Raymond James Starts Ionis Pharmaceuticals (IONS) at Outperform, 'Taking Returns to Heart (and Mind)'

April 9, 2026 4:26 PM
(Updated - April 9, 2026 4:28 PM EDT)

Raymond James analyst Tiago Fauth initiates coverage on Ionis Pharmaceuticals (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage